Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy

Neethu Mohan Menon, Emmanuel Katsanis, Zain I Khalpey, Puja Whitlow

Research output: Contribution to journalArticle

3 Scopus citations


Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of the hematopoietic stem cell that is exceptionally rare in the first five years of life, particularly as a secondary malignancy. This report describes a case of secondary CML in a four-year-old female occurring after AML treatment. Interestingly, CML developed while on immunosuppression for a heart transplant due to anthracycline-induced cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)166-168
Number of pages3
JournalPediatric Blood and Cancer
Issue number1
Publication statusPublished - Jan 1 2015



  • AML
  • CML
  • Heart transplant
  • Secondary malignancy

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Medicine(all)

Cite this